Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

CYCLOPHARM LIMITED

INVESTOR PRESENTATION - CYCLOPHARM LIMITED

ASX:CYC

CYCLOPHARM LIMITED

Health Care

Cyclopharm Limited (CYC) is a radiopharmaceutical company focusing on the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. Its products are Technegas and Molecular Imaging, which are offered to nuclear medicine departments in hospitals and clinics in Europe, North America and Asia Pacific.

Read more

Market Cap

$176.60m

Price at Close

$2.2

4w avg. Volume

4.58k

4w avg. Turnover

$9.54k

Announcements
announcementt+2 movementdate
  • Bell Potter Healthcare Conference

    Periodic Reports

  • -

    25 Nov 2020

-

25 Nov 2020
  • Change of Director's Interest Notice TM

    Shareholder Details

  • +0.50%

    22 Oct 2020

+0.50%

22 Oct 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • -1.26%

    01 Oct 2020

-1.26%

01 Oct 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +5.31%

    29 Sep 2020

+5.31%

29 Sep 2020
  • Cyclopharm Investor Presentation

    Periodic Reports · Market sensitive

  • -1.70%

    22 Sep 2020

-1.70%

22 Sep 2020
  • Technegas USA Trial Successfully Meets Primary Endpoint

    Progress Report · Market sensitive

  • +65.30%

    15 Sep 2020

+65.30%

15 Sep 2020
  • CYC Partners With McMasters University In COVID-19 Research

    Progress Report

  • +1.83%

    08 Sep 2020

+1.83%

08 Sep 2020
  • Half Year 2020 Financial Results

    Periodic Reports

  • +1.15%

    25 Aug 2020

+1.15%

25 Aug 2020
  • Half Yearly Report and Accounts

    Periodic Reports · Market sensitive

  • +1.15%

    25 Aug 2020

+1.15%

25 Aug 2020
  • Dividend/Distribution - CYC

    Dividend Announcement · Market sensitive

  • +1.15%

    25 Aug 2020

+1.15%

25 Aug 2020
Market Data

Current Price

$2.2

52WK HIGH

$3.3

52WK LOW

$0.7

1YR RETURN

+94.69%

1YR RETURN VS. SECTOR

+61.27%

90 DAY RETURN

+66.67%

ASX RANK

622

/2,024

SECTOR RANK

6

/28

SHARES OUTSTANDING

80.27m
ASX:CYC

CYCLOPHARM LIMITED

Health Care

Cyclopharm Limited (CYC) is a radiopharmaceutical company focusing on the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. Its products are Technegas and Molecular Imaging, which are offered to nuclear medicine departments in hospitals and clinics in Europe, North America and Asia Pacific.

Read more

Market Cap

$176.60m

Price at Close

$2.2

4w avg. Volume

4.58k

4w avg. Turnover

$9.54k

ASX:CYC is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.